Multiple-adjusted coronary heart disease relative risks (and 95% CIs) for women and men, comparing those with, to those without, diabetes, by study
| Study | Women | Men |
| Adventist | 2.15 (1.33 to 3.47) | 2.11 (1.12 to 4.00) |
| APCSC (ANZ) | 2.01 (1.55 to 2.60) | 1.58 (1.32 to 1.90) |
| APCSC (Asia) | 1.82 (1.02 to 3.25) | 1.47 (1.15 to 1.88) |
| ARIC | 3.16 (2.64 to 3.78) | 2.38 (2.02 to 2.80) |
| Collins (Indians) | 20.70 (2.51 to 171) | 3.15 (1.29 to 7.69) |
| Collins (Melanesians) | 5.36 (1.18 to 24.3) | 1.60 (0.43 to 5.97) |
| DECODE | 2.48 (1.69 to 3.65) | 2.09 (1.55 to 2.82) |
| Dubbo | 1.67 (1.12 to 2.48) | 1.53 (0.99 to 2.37) |
| EPESE | 3.20 (1.46 to 7.01) | 1.75 (0.97 to 3.16) |
| Framingham | 5.4 (2.4 to 12.3) | 6.1 (3.4 to 10.9) |
| Hawaii/LA/Hisoshima | 3.29 (1.79 to 6.55) | 1.54 (1.03 to 2.25) |
| Hisayama | 3.46 (1.59 to 7.54) | 1.26 (0.67 to 2.35) |
| HUNT I | 2.50 (2.10 to 2.80) | 1.80 (1.60 to 2.10) |
| Kuopio and N Karelia | 4.89 (3.84 to 6.24) | 2.11 (1.70 to 2.63) |
| NHANES I | 2.59 (1.59 to 4.22) | 2.37 (1.55 to 3.62) |
| NHANES III | 2.53 (1.62 to 3.97) | 1.29 (0.91 to 1.85) |
| Renfrew and Paisley | 1.97 (1.27 to 3.08) | 1.17 (0.78 to 1.74) |
| Reykjavik | 2.23 (1.50 to 3.32) | 1.34 (0.97 to 1.87) |
| SHHEC | 3.06 (2.18 to 4.27) | 2.49 (1.84 to 3.37) |
| Strong | 2.26 (1.73 to 2.96) | 1.66 (1.30 to 2.12) |
| Takayama | 0.49 (0.07 to 3.57) | 2.96 (1.59 to 5.50) |
For citations to the studies (identified here by authors or study names), see Peters et al ,18 from where the data were obtained.